We will continue the tradition of the Trainee Day, hosted and supported by Ovarian Cancer Canada.

Preliminary Program Agenda: Friday June 12, 2020

08:00-08:10 Welcome remarks
Barbara Vanderhyden, Co-Chair CCOCR 2020 Organizing Committee
Elisabeth Baugh, Ovarian Cancer Canada
08:10-09:10 Pathobiology of ovarian cancer
08:10
Basic overview of ovarian cancer pathobiology
Trainees will learn about the unique histopathology of the most common types of ovarian cancer, including characteristic biomarkers
08:30
Endometriosis:
A precursor of ovarian cancer?
Trainees will be presented with data supporting the role of endometriosis in endometrioid and clear cell carcinoma
08:50
Understanding the tumour microenvironment
09:10-10:30 Clinical management
09:10
Overview of current clinical management
Description of the “typical” clinical course of women from time of diagnosis, through treatment, to end of life
09:30
Emerging role of immune therapy in ovarian cancer treatment

Trainees will be presented with data on different immune therapies that may benefit women with ovarian cancer
09:50
PARP inhibition: Recent findings and implications for women with ovarian cancer
10:10-10:25 Break
10:25-11:10
Living with cancer: A survivor perspective
Moderated by Ovarian Cancer Canada
11:10-11:50 Risk and prevention
11:10
Inherited predisposition and genetic counselling
Trainees will learn about the contribution of inherited mutations in BRCA1 and 2, Lynch Syndrome genes and emerging moderate risk genes to hereditary ovarian cancer, and the important role of genetic counselling
11:30
Surgical and non-surgical options for ovarian cancer risk reduction
Trainees will learn about the surgical options for risk reduction in women at high risk and the general population, in addition to non-surgical alternatives such as oral contraceptives and aspirin
11:50-12:40
Lunch
12:40-13:55 The scientific tool box/advances in ovarian cancer “omics”
12:40
Experimental models of ovarian cancer
Trainees will learn about the advantages and drawbacks of available model systems, such as cell culture, patient-derived xenografts and mouse models
13:05
Technique spotlight: Single cell RNA-Seq
.
13:30
Sample type spotlight: Circulating tumour DNA (ctDNA) as a non-invasive monitoring too
13:55-14:00 Closing and Evaluations
 

Trainees are invited to join the GOC’s 40th Anniversary Annual General Meeting as of 15:00 at the Westin Ottawa hotel.
This is part of the Trainee Day registration fee.

 

15:05-16:20

Scientific Session III – Ovarian Cancer related presentations (5)

16:20-16:25

People’s choice voting for best oral, poster and video presentations

16:25-16:30

Announcements